ZEVRA THERAPEUTICS, INC. (ZVRA)

Key Insights

• Insider Justin A. Renz, the CFO of Zevra Therapeutics, was granted a stock option to acquire 300,000 shares of the company's common stock at an exercise price of $9.55 per share.
• The stock option will vest in four equal annual installments, with full acceleration upon a change of control or if Renz is terminated without cause or resigns for good reason.
• The grant of this stock option aligns the interests of the CFO with those of the shareholders and provides an incentive for Renz to continue driving the company's growth and performance.